🇺🇸 FDA
Patent

US 11352365

Biased potent opioid-like agonists as improved medications to treat chronic and acute pain and methods of using the same

granted A61PA61P29/00

Quick answer

US patent 11352365 (Biased potent opioid-like agonists as improved medications to treat chronic and acute pain and methods of using the same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P29/00